# EOFlow signs 48.8B KRW supply deal for EOPatch insulin pump with Gulf Drug

EOFlow signed a contract with Gulf Drug of the UAE to supply 48.8 billion won ($40 million) worth of EOPatch wearable insulin pumps over five years. Gulf Drug will have exclusive sales rights in the GCC.

- Type: Contract
- Announced: 2022-03-31
- Where: Dubai, UAE, United Arab Emirates
- Value: $40.0M (48.8B KRW)
- Status: announced
- Products: EOPatch wearable insulin pump
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [EOFlow](https://endata.com/companies/55385.md)
- [Gulf Drug](https://endata.com/companies/62069.md) (customer)

## Sources

- [businesskorea.co.kr](https://www.businesskorea.co.kr/news/articleView.html?idxno=90178), 2022-04-04: "I am excited for EOFlow's additional market expansion in 2022 in the Middle East."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.